Contact Info
- 1616 W. Cape Coral Pkwy
- #135
- Cape Coral, FL 33914
- Website: http://www.naturesbioceuticals.com
- Phone: 561-200-7300
- Email: sales@naturesbioceuticals.com
Verify Company Info
Business Description
Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature?s Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs. Nature's line of n...
More >>
Financial Reporting/Disclosure
| Reporting Status | Dark: Alternative Reporting Standard
Deregistered a/o Aug 14, 2008 |
| Audited Financials | Unaudited |
| Latest Report | Sep 30, 2012 Quarterly Report |
| CIK | 0001329944 |
| Fiscal Year End | 12/31 |
| OTC Market Tier | OTC Pink No Information |
Profile Data
| SIC - Industry Classification | 2833 - Medicinal and botanicals |
| Business Status | Development Stage Company a/o Sep 30, 2006 |
| Shell | |
| Incorporated In: | NV, USA |
| Year of Inc. | 2007 |
| Employees | 1 a/o Mar 31, 2010 |
Company Officers/Contacts
| Robert Dezanger | President, CEO |
| Lisa Zuck | Secretary, Treasurer |
Company Directors
| Not Available |
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Investor Relations Firm
Not Available
MILV Security Details
Share Structure
| Market Value1 | $769,784 | a/o May 22, 2013 |
| Shares Outstanding | 962,230,600 | a/o Sep 30, 2012 |
| Float | Not Available | |
| Authorized Shares | 1,125,000,000 | a/o Dec 31, 2011 |
| Par Value | 0.0001 |
Shareholders
| Shareholders of Record | 66 | a/o Oct 17, 2011 |
Short Selling Data
| Short Interest | 0 (-100%) Mar 15, 2013 |
| Significant Failures to Deliver | No |
Transfer Agent(s)
| Signature Stock Transfer, Inc. |
1Market Value calculated only for respective security



